医学分子生物学杂志 ›› 2025, Vol. 22 ›› Issue (4): 361-367.doi: 10.3870/j.issn.1672-8009.2025.04.009

• 论著 • 上一篇    下一篇

丹参酮Ⅱ A 通过 MALAT1 靶向 miR-143 调控结肠癌 SW480细胞增殖侵袭和迁移 #br#

  

  1. 厦门大学附属翔安医院1胃肠外科,2普外科 福建省厦门市, 361100
  • 出版日期:2025-07-31 发布日期:2025-07-18
  • 基金资助:
    福建省医学科研计划项目 (No. 2023D034)

Tanshinone Ⅱ A Regulates Proliferation, Invasion, and Migration of Colon Cancer SW480 Cells by Targeting miR-143 via MALAT1 #br#

  1. 1Department of Gastrointestinal Surgery,2Department of General Surgery, Xiangan Hospital Affiliated to Xiamen University, Xiamen, Fujian, 361100, China
  • Online:2025-07-31 Published:2025-07-18

摘要: 目的 丹参酮Ⅱ A (tanshinone Ⅱ A) 通过肺癌转移相关转录本 1 ( metastasis-associated lung adenocarcinoma transcript 1, MALAT1) 靶向 miR-143 对结肠癌 SW480 细胞增殖侵袭和迁移的影响方法 选择 0、 10、 20、 40 μmol / L 剂量的丹参酮Ⅱ A 处理 SW480 细胞, 将细胞随机分为 4 : Control , 丹参酮Ⅱ A 高剂量组。 CCK8 实验检测细胞增殖倍数细胞划痕实验和 Transwell 实验检测细胞迁移侵袭。RT-PCR 检测 MALAT1、 miR-143 mRNA 水平荧光素酶报告实验进一步验证 miR-143 靶向结合 MALAT1 的关系单独或联合转染 pcDNA-MALAT1 miR-143 mimic 40 μmol / L 剂量丹参酮Ⅱ A 处理后的 SW480 细胞, 将细胞随机分为 5 : Control 、 pcDNA 3. 1 、 pcDNA-MALAT1 、 MALAT1 + mimic NC 组和 MALAT1 + miR-143 mimic , 检测各组细胞检测增殖侵袭及迁移结果 Control 组比较, 丹参酮Ⅱ A 高剂量组细胞增殖倍数侵袭细胞数划痕愈合率和 MALAT1 mRNA 水平显著降低 ( P< 0. 05), miR-143 mRNA 水平显著升高 ( P < 0. 05); MALAT1 miR-143 存在靶向作用关系pcDNA-MALAT1 组比较, MALAT1 + miR-143 mimic 组细胞增殖倍数侵袭细胞数和划痕愈合率显著降低 (P< 0. 05)。 结论 丹参酮Ⅱ A 通过 MALAT1 / miR-143 轴发挥抗结肠癌作用

关键词: 结肠癌, 丹参酮Ⅱ A, 肺癌转移相关转录本 1, miR-143

Abstract: Objective To investigate the effect of tanshinone Ⅱ A on proliferation, invasionand migration of colon cancer SW480 cells by targeting miR-143 via metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) . Methods SW480 cells were treated with 0, 10, 20, and40 μmol / L of tanshinone Ⅱ A, and were randomly divided into 4 groups: Control group, tanshinone Ⅱ A low-, medium-, and high-dose groups. CCK8 assay was used to detect cellproliferation. Wound-healing and Transwell assay were used to detect the number of migrated and invaded cells. The expression levels of MALAT1 and miR-143 mRNA were detected by RT-PCR. Theluciferase gene reporter assay was used to verify the targeting relationship between MALAT1 andmiR-143. SW480 cells treated with tanshinone Ⅱ A (40 μmol / L) were transfected with pcDNA MALAT1 and miR-143 mimic separately or combined, and were randomly divided into 5 groups:Control group, PCDNA 3. 1 group, pcDNA-MALAT1 group, MALAT1 + mimic NC group, and MALAT1 + miR-143 mimic group. The proliferation, invasion, and migration of cells in the abovegroups were detected. Results Compared with those in the Control group, the cell proliferation,number of invaded cells, wound-healing rate, and MALAT1 mRNA expression level in the tanshinone Ⅱ A medium-dose and high-dose groups were significantly decreased ( P < 0. 05), and the miR-143 mRNA expression level was significantly increased (P< 0. 05) . MALAT1 has a targetingrelationship with miR-143. Compared with those in the pcDNA-MALAT1 group, the cell proliferation, number of invaded cells, and wound-healing rate in the MALAT1 + miR-143 mimic groupwere significantly decreased (P< 0. 05) . Conclusion Tanshinone Ⅱ A exerts its anti-colon cancer effect through theMALAT1 / miR-143 axis.

Key words:

colon cancer, tanshinone Ⅱ A, metastasis-associated lung adenocarcinoma transcript 1, miR-143

中图分类号: